Answers are grounded in this paper and cite their sources.
This research compares cold sintering and pressureless sintering for improving bioceramic density, suggesting a better alternative method.
Hydroxyapatite (HAp) is a key bioceramic for biomedical applications, but conventional pressureless sintering (PS) requires high temperatures that can promote phase degradation. Here, we compare PS (1100 °C/180 min) and cold sintering process (CSP) (150 °C/450 MPa/30 min) for pure HAp and an HAp composite containing 4 wt.% niobium–phosphate bioglass (BG), using a 2 M H3PO4 transient liquid (10 wt.%). CSP increased relative density from 73.10% to 79.92% for HAp and from 68.43% to 83.54% for HAp/BG, representing up to a 22.1% gain compared with PS. One-way ANOVA confirmed a significant effect of processing route/composition on relative density (F(3,24) = 919.69, p < 0.05), and Tukey HSD indicated that all groups differed statistically. SEM revealed a markedly more consolidated and homogeneous microstructure for CSP, particularly for HAp/BG, consistent with enhanced dissolution–reprecipitation and pore filling. XRD showed that PS at 1100 °C led to partial HAp degradation with β-TCP formation, whereas CSP preserved the HAp phase with broader peaks, smaller crystallite size, and higher specific surface area. These results demonstrate CSP as an efficient low-temperature alternative for densifying HAp-based bioceramics, with BG addition further improving consolidation.
No takes yet. Share an insight, caveat, or question.
Silveira et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: